NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
about
Pharmacology of manipulating lean body massInflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical ExerciseDistinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophyMagnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and εA Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsTNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophyRegulatory interactions between muscle and the immune system during muscle regenerationEffect of photobiomodulation on expression of IL-1β in skeletal muscle following acute injury.β-agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms.Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cellsApproaching a new age in Duchenne muscular dystrophy treatment.Muscle Wasting in Fasting Requires Activation of NF-κB and Inhibition of AKT/Mechanistic Target of Rapamycin (mTOR) by the Protein Acetylase, GCN5.Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice.Emerging use of stem cells in regenerative medicine.Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.Metabolic and structural impairment of skeletal muscle in heart failure.Mechanisms of muscle injury, repair, and regeneration.Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology.Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle HomeostasisSkeletal Muscle Changes in Chronic Cardiac Disease and Failure.Resistance exercise increases intramuscular NF-κb signaling in untrained males.Sarcopenia in critically ill patients.TNF- α and IFN-s-dependent muscle decay is linked to NF-κB- and STAT-1α-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes.Ibuprofen supplementation and its effects on NF-κB activation in skeletal muscle following resistance exercise.Transcriptomics, NF-κB Pathway, and Their Potential Spaceflight-Related Health Consequences.The muscle contraction mode determines lymphangiogenesis differentially in rat skeletal and cardiac muscles by modifying local lymphatic extracellular matrix microenvironments.Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice.The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy.Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.A rat model of massive rotator cuff tears.Interleukin-1beta (IL-1β)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1β on human dystrophic myogenic cells.Evaluating the essential role of RONS in vivo in exercised human muscle.Curcumin counteracts loss of force and atrophy of hindlimb unloaded rat soleus by hampering neuronal nitric oxide synthase untethering from sarcolemma.Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice.Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.
P2860
Q26824503-32917D0B-7909-488F-9C4B-EBB611D713B7Q28076878-A5790E07-7EEB-4E52-B471-6ED13B0A4D2BQ28393718-7547064B-F495-400D-8624-C521E3FC7540Q28548194-82A099BF-594E-4F89-8366-5A2F147F0767Q28743444-81E1E164-772D-4417-B047-6432DFAF8402Q33625958-CC97FADA-23D1-4076-AC09-50761635523AQ33683329-04589CB6-4F98-4492-B2C1-0F2EE70AB580Q33841066-21087935-0C2A-4ECD-AE7F-1B9906356BAAQ34487893-6AF79283-6BC6-4AA7-A024-4220172C2DF4Q35113012-959BE563-98B4-4171-83CB-71F7C4D99A20Q35612938-9DDB83F6-E3C3-4B2D-AD2B-E1A90A391C26Q35888398-9E90ACAD-88F2-4024-AD64-1B06F6C6172CQ36381895-AB2BDB32-A981-4BF4-8CFB-FC942AE608E1Q36621772-29ED69BA-F9F2-4410-8703-6851564C7BA7Q37737762-B4FB317C-A3AF-4250-B4C9-F13C6584A4BDQ37912719-10442589-CD57-4A58-AF8C-E87ECB781D76Q38052031-D878632C-D65E-4FD1-B007-C5F1C56E7616Q38111732-279CF8B1-17A8-49F8-B017-C006B4C651A3Q38164574-1687C12B-699F-4FB6-B056-3AD15ADD28EDQ38189358-CC2DA2CA-18D8-45E1-A79F-1BD136E5D331Q38596709-04A9BD20-1BA7-4CC8-9508-3AA052580910Q38825650-9E7CD08D-AD21-4DFE-A4E0-0C17253ED4D3Q38885552-5C51B7BC-9E15-41BF-81B2-35D990D4111FQ39031553-5DDFD6E9-302F-4409-A302-37941A38351DQ39129171-9957C67A-4ACA-47AC-BA15-2F363BD1A2DEQ39340507-0DA49179-77F2-4BBF-A7AD-15CCDDF16D91Q40280942-05A22921-53AB-4403-A1E9-1399A525E777Q41045084-9DA0A33D-8EE3-4438-93FA-613A72BAF8F0Q41717334-645C3762-2370-4397-934C-C541E2DAEF99Q42754638-393E6BE9-90C9-4D5B-9C67-70381E81B01DQ45863094-EACD0DC6-CEDD-472B-BF86-2CDCAD7B0AA9Q45946660-907CBCA0-F312-4BAA-88B6-80B6C291D612Q47148629-15A7388E-801A-43EB-B03C-6D4CB7F04045Q50191757-8F2420E2-3CAE-43EA-A9B5-3027C8890308Q52649191-7ACA38AE-9630-4E51-9256-341785D79BEFQ52926464-B5A6AB03-73C9-4610-B5D1-C5BDA2C0608AQ54739404-FBB6437F-2548-454C-902C-2A1907D89E8C
P2860
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
@en
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases.
@nl
type
label
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
@en
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases.
@nl
prefLabel
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
@en
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases.
@nl
P2860
P921
P1476
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases
@en
P2093
Foteini Mourkioti
Nadia Rosenthal
P2860
P2888
P304
P356
10.1007/S00109-008-0308-4
P577
2008-02-02T00:00:00Z